supported by grants from CAMS Innovation Fund for Medical Sciences (CIFMS) (2022-I2M-2-002,2021-I2M-1030,China);National Natural Science Foundation of China (No.81473249 and 81102464);Drug Innovation Major Project of China (2018ZX09711001-007-002);National Key Research and Development Program of China (2016YFA0201504);National Mega-project for Innovative Drugs (2014ZX09201042,China)。
Pancreatic cancer is a more aggressive and refractory malignancy.Resistance and toxicity limit drug efficacy.Herein,we report a lower toxic and higher effective miriplatin(MPt)-loaded liposome,LMPt,exhibiting totally ...
Objective Mutations in polymerase gamma gene(POLG)are believed to be an important cause of early and juvenile onset of non-syndromic intractable epilepsy.The aim of this study is to investigate the incidence/prevalenc...